CNC official logo CNC
CNC 1-star rating from Upturn Advisory
Centene Corp (CNC) company logo

Centene Corp (CNC)

Centene Corp (CNC) 1-star rating from Upturn Advisory
$46.61
Last Close (24-hour delay)
Profit since last BUY17.52%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 31 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/09/2026: CNC (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

3 star rating from financial analysts

19 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $43.06

1 Year Target Price $43.06

Analysts Price Target For last 52 week
$43.06 Target price
52w Low $25.08
Current$46.61
52w High $66.81

Analysis of Past Performance

Type Stock
Historic Profit -5.4%
Avg. Invested days 35
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/09/2026

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 22.91B USD
Price to earnings Ratio -
1Y Target Price 43.06
Price to earnings Ratio -
1Y Target Price 43.06
Volume (30-day avg) 19
Beta 0.48
52 Weeks Range 25.08 - 66.81
Updated Date 01/9/2026
52 Weeks Range 25.08 - 66.81
Updated Date 01/9/2026
Dividends yield (FY) -
Basic EPS (TTM) -10.67

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.16%
Operating Margin (TTM) 0.55%

Management Effectiveness

Return on Assets (TTM) 2.01%
Return on Equity (TTM) -21.86%

Valuation

Trailing PE -
Forward PE 15.65
Enterprise Value 21408024560
Price to Sales(TTM) 0.14
Enterprise Value 21408024560
Price to Sales(TTM) 0.14
Enterprise Value to Revenue 0.12
Enterprise Value to EBITDA 3.91
Shares Outstanding 491518000
Shares Floating 489114477
Shares Outstanding 491518000
Shares Floating 489114477
Percent Insiders 0.45
Percent Institutions 96.67

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Centene Corp

Centene Corp(CNC) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Centene Corporation was founded in 1984 by Michael F. Neidorff in Madison, Wisconsin, initially as a healthcare provider for low-income families. The company has since evolved significantly, focusing on government-sponsored healthcare programs. Key milestones include its initial public offering in 1997, numerous strategic acquisitions to expand its reach and capabilities, and its substantial growth fueled by the Affordable Care Act (ACA). Centene has become a leading managed care organization serving Medicaid, Medicare, and Health Insurance Marketplace plans.

Company business area logo Core Business Areas

  • Managed Care: Centene provides a comprehensive range of managed care services through its health plans. This includes managing benefits for Medicaid, Medicare, and Health Insurance Marketplace members, often serving vulnerable populations and those with chronic conditions. Services encompass medical, behavioral, and pharmacy benefits management.
  • Specialty Services: This segment includes specialized healthcare services such as behavioral health, care management, and pharmacy benefits management (PBM). These services are often integrated within their managed care offerings or provided as standalone solutions.
  • Technology and Data Analytics: Centene invests in technology and data analytics to improve care quality, manage costs, and enhance member experience. This includes developing platforms for population health management and predictive analytics.

leadership logo Leadership and Structure

Centene is led by a seasoned executive team. The organizational structure is largely segmented by product lines and geographic regions, with a focus on managing its diverse portfolio of government-sponsored health plans. Key leadership roles include the Chief Executive Officer, Chief Financial Officer, and heads of various operational and strategic divisions.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Medicaid Managed Care: Centene is a major provider of Medicaid managed care plans, offering comprehensive health coverage to low-income individuals and families. This is their largest and most significant business segment, serving millions of members across numerous states. Competitors include UnitedHealth Group (through UnitedHealthcare Community Plan), Elevance Health (through various Anthem BCBS plans), and CVS Health (through Aetna Medicaid).
  • Health Insurance Marketplace Plans: Centene offers plans on the Health Insurance Marketplace (ACA exchanges), providing subsidized health insurance to individuals and families who do not have employer-sponsored coverage. Competitors include UnitedHealth Group, Elevance Health, and Kaiser Permanente (in specific markets).
  • Medicare Advantage Plans: The company also provides Medicare Advantage (Part C) plans, which are private insurance alternatives to traditional Medicare. This segment is growing for Centene. Competitors include UnitedHealth Group, Humana, and CVS Health (through Aetna).
  • Pharmacy Benefit Management (PBM) - Magellan Rx: Through its subsidiary Magellan Rx, Centene offers PBM services, including prescription drug benefit management, specialty pharmacy, and drug formulary management. Competitors include Express Scripts (Cigna), Optum Rx (UnitedHealth Group), and Caremark (CVS Health).

Market Dynamics

industry overview logo Industry Overview

The managed care industry in the US is heavily influenced by government policies and regulations, particularly regarding Medicaid, Medicare, and the ACA. The industry is characterized by intense competition, a focus on cost containment, and an increasing demand for integrated care solutions, including behavioral health and pharmacy benefits. Consolidation has been a significant trend, with larger players seeking scale and broader service offerings.

Positioning

Centene is a leading national provider of government-subsidized healthcare programs, with a particular strength in Medicaid managed care. Its competitive advantages lie in its deep experience serving vulnerable populations, its extensive geographic footprint, and its integrated approach to care management. The company has a proven track record of growth through acquisitions and organic expansion.

Total Addressable Market (TAM)

The total addressable market for government-sponsored healthcare programs in the US is vast and continues to grow, driven by an aging population, expanding eligibility for Medicaid, and ongoing healthcare reform efforts. Centene is well-positioned to capture a significant portion of this TAM, particularly within the Medicaid and Health Insurance Marketplace segments, due to its scale and specialized focus.

Upturn SWOT Analysis

Strengths

  • Strong market position in government-sponsored healthcare programs (Medicaid, Medicare, Marketplace).
  • Extensive geographic reach across 50 states.
  • Proven track record of successful acquisitions and integration.
  • Focus on serving vulnerable populations and managing complex care needs.
  • Integrated care model encompassing medical, behavioral, and pharmacy benefits.

Weaknesses

  • Reliance on government reimbursement rates and regulatory changes.
  • Integration challenges with large-scale acquisitions.
  • Potential for operational inefficiencies due to rapid growth.
  • Competition from larger, more diversified healthcare companies.

Opportunities

  • Expansion into new state Medicaid contracts.
  • Growth in Medicare Advantage and dual-eligible populations.
  • Increased demand for integrated behavioral health services.
  • Leveraging technology and data analytics for improved care and cost management.
  • Partnerships with providers and community organizations.

Threats

  • Changes in healthcare policy and regulation (e.g., ACA repeal/replace, Medicaid block grants).
  • Increased competition and pricing pressure.
  • Rising healthcare costs and medical trend inflation.
  • Cybersecurity risks and data breaches.
  • Economic downturns impacting government budgets.

Competitors and Market Share

Key competitor logo Key Competitors

  • UnitedHealth Group (UNH)
  • Elevance Health (ELV)
  • CVS Health (CVS)
  • Humana (HUM)

Competitive Landscape

Centene competes in a highly fragmented but consolidating market. Its primary advantages are its deep specialization in government-sponsored programs and its scale in serving vulnerable populations. However, it faces strong competition from larger, more diversified companies like UnitedHealth Group and Elevance Health, which have broader market penetration and more extensive integrated offerings. Centene's ability to execute on integrations and manage costs effectively are key to its competitive standing.

Major Acquisitions

WellCare Health Plans

  • Year: 2020
  • Acquisition Price (USD millions): 17300
  • Strategic Rationale: The acquisition of WellCare significantly expanded Centene's scale and market presence, particularly in Medicaid and Medicare Advantage, solidifying its position as a leading government-focused managed care organization.

Magellan Health

  • Year: 2022
  • Acquisition Price (USD millions): 18500
  • Strategic Rationale: This acquisition bolstered Centene's behavioral health capabilities and strengthened its position in the pharmacy benefit management (PBM) sector through Magellan Rx, enabling a more comprehensive and integrated approach to healthcare services.

Growth Trajectory and Initiatives

Historical Growth: Centene has experienced robust historical growth, largely fueled by strategic acquisitions that have expanded its membership base and geographic footprint. The company has consistently grown its revenue by acquiring other health plans, particularly those focused on government-sponsored programs.

Future Projections: Analyst projections for Centene's future growth typically focus on continued expansion within its core Medicaid and Medicare segments, as well as potential gains from new contract wins and the ongoing integration of acquired businesses. Growth is also expected from its specialty services and PBM segment.

Recent Initiatives: Recent initiatives have included efforts to streamline operations, enhance technological capabilities for better care management and data analytics, and focus on improving quality outcomes and member satisfaction within its health plans. The company has also been actively managing its portfolio, divesting non-core assets and strengthening its core government business.

Summary

Centene Corp is a dominant player in the US government-sponsored healthcare market, particularly Medicaid, with a proven growth strategy driven by acquisitions. Its strengths lie in serving vulnerable populations and its extensive geographic reach. However, it faces significant threats from regulatory changes and intense competition from larger, diversified players. The company needs to focus on operational efficiencies and leveraging its integrated care model to maintain its competitive edge and navigate the complex healthcare landscape.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Centene Corporation Annual Reports (10-K)
  • Centene Corporation Quarterly Reports (10-Q)
  • Company Investor Relations Website
  • Reputable Financial News Outlets (e.g., Bloomberg, Wall Street Journal)
  • Industry Analysis Reports

Disclaimers:

The information provided is for informational purposes only and does not constitute financial advice. This analysis is based on publicly available data and may not reflect all nuances of the company's operations or market conditions. Investing in the stock market involves inherent risks, and investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Market share percentages are estimates and can fluctuate.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Centene Corp

Exchange NYSE
Headquaters Saint Louis, MO, United States
IPO Launch date 2001-12-13
CEO & Director Ms. Sarah M. London
Sector Healthcare
Industry Healthcare Plans
Full time employees 60500
Full time employees 60500

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.